These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 31527063)
1. A novel benzoxazinone derivative YLT-LL-11 inhibits diffuse large B-cell lymphoma growth via inducing cell cycle arrest and apoptosis. Peng C; Sun C; Wang N; He Y; Xu J; Deng Y; Gao L; Zhong J; Xiong X; Liu L Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31527063 [TBL] [Abstract][Full Text] [Related]
2. Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2. Mahadevan D; Morales C; Cooke LS; Manziello A; Mount DW; Persky DO; Fisher RI; Miller TP; Qi W PLoS One; 2014; 9(6):e95184. PubMed ID: 24893165 [TBL] [Abstract][Full Text] [Related]
3. HDAC inhibitor chidamide synergizes with venetoclax to inhibit the growth of diffuse large B-cell lymphoma via down-regulation of MYC, BCL2, and TP53 expression. Luo C; Yu T; Young KH; Yu L J Zhejiang Univ Sci B; 2022 Aug; 23(8):666-681. PubMed ID: 35953760 [TBL] [Abstract][Full Text] [Related]
4. Novel synthetic 4-chlorobenzoyl berbamine inhibits c-Myc expression and induces apoptosis of diffuse large B cell lymphoma cells. Zhang L; Tong J; He X; Liang Y; Zhu L; Xu R; Zhao X Ann Hematol; 2018 Dec; 97(12):2353-2362. PubMed ID: 30099568 [TBL] [Abstract][Full Text] [Related]
5. Matrine suppresses cell growth of diffuse large B-cell lymphoma via inhibiting CaMKIIγ/c-Myc/CDK6 signaling pathway. Gu J; Wang X; Zhang L; Xiang J; Li J; Chen Z; Zhang Y; Chen J; Shen J BMC Complement Med Ther; 2021 Jun; 21(1):163. PubMed ID: 34088288 [TBL] [Abstract][Full Text] [Related]
6. A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma: Role of cyclin-dependent kinase inhibitors. Tula-Sanchez AA; Havas AP; Alonge PJ; Klein ME; Doctor SR; Pinkston W; Glinsmann-Gibson BJ; Rimsza LM; Smith CL Cancer Biol Ther; 2013 Oct; 14(10):949-61. PubMed ID: 23982416 [TBL] [Abstract][Full Text] [Related]
7. Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors. Li W; Gupta SK; Han W; Kundson RA; Nelson S; Knutson D; Greipp PT; Elsawa SF; Sotomayor EM; Gupta M J Hematol Oncol; 2019 Jul; 12(1):73. PubMed ID: 31288832 [TBL] [Abstract][Full Text] [Related]
8. A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway. Lu K; Li B; Zhang H; Xu Z; Song D; Gao L; Sun H; Li L; Wang Y; Feng Q; Chen G; Hu L; Wei R; Xie Y; Yu D; Wu X; Zhu W; Shi J Signal Transduct Target Ther; 2020 Apr; 5(1):31. PubMed ID: 32296013 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of bromodomain and extra-terminal proteins targets constitutively active NFκB and STAT signaling in lymphoma and influences the expression of the antiapoptotic proteins BCL2A1 and c-MYC. Pieper NM; Schnell J; Bruecher D; Knapp S; Vogler M Cell Commun Signal; 2024 Aug; 22(1):415. PubMed ID: 39192247 [TBL] [Abstract][Full Text] [Related]
10. Novel cyclophosphamide of natural products osalmide and pterostilbene induces cytotoxicity and cell cycle arrest in diffuse large B-cell lymphoma cells. Xi M; He W; Li B; Zhou J; Xu Z; Wu H; Zhang Y; Song D; Hu L; Lu Y; Bu W; Kong Y; Chen G; Chang S; Shi J; Zhu W Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):401-410. PubMed ID: 32259210 [TBL] [Abstract][Full Text] [Related]
11. Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate. Holien T; Olsen OE; Misund K; Hella H; Waage A; Rø TB; Sundan A Eur J Haematol; 2013 Oct; 91(4):339-46. PubMed ID: 23869695 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma. Trabucco SE; Gerstein RM; Evens AM; Bradner JE; Shultz LD; Greiner DL; Zhang H Clin Cancer Res; 2015 Jan; 21(1):113-22. PubMed ID: 25009295 [TBL] [Abstract][Full Text] [Related]
13. PIK3CD promoted proliferation in diffuse large B cell lymphoma through upregulation of c-myc. Cui W; Zheng S; Li X; Ma Y; Sang W; Liu M; Zhang W; Zhou X Tumour Biol; 2016 Sep; 37(9):12767-12777. PubMed ID: 27448819 [TBL] [Abstract][Full Text] [Related]
14. The rGel/BLyS fusion toxin inhibits STAT3 signaling via down-regulation of interleukin-6 receptor in diffuse large B-cell lymphoma. Lyu MA; Sung B; Cheung LH; Marks JW; Aggarwal BB; Aguiar RC; Rosenblum MG Biochem Pharmacol; 2010 Nov; 80(9):1335-42. PubMed ID: 20654581 [TBL] [Abstract][Full Text] [Related]
15. Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma. Jin Z; Qing K; Ouyang Y; Liu Z; Wang W; Li X; Xu Z; Li J J Exp Clin Cancer Res; 2016 Mar; 35():52. PubMed ID: 27009084 [TBL] [Abstract][Full Text] [Related]
16. Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma. Hashiguchi T; Bruss N; Best S; Lam V; Danilova O; Paiva CJ; Wolf J; Gilbert EW; Okada CY; Kaur P; Drew L; Cidado J; Hurlin P; Danilov AV Mol Cancer Ther; 2019 Sep; 18(9):1520-1532. PubMed ID: 31243099 [TBL] [Abstract][Full Text] [Related]
17. SENP1 knockdown potentiates the apoptosis, cell cycle arrest, and reduces cisplatin resistance of diffuse large B cell lymphoma cells via inducing ferroptosis. Dong J; Zheng X Biochem Cell Biol; 2024 Aug; 102(4):319-330. PubMed ID: 38708853 [TBL] [Abstract][Full Text] [Related]
18. Arsenic disulfide induces apoptosis of human diffuse large B cell lymphoma cells involving Bax cleavage. Wang L; Liu X; Li X; Lv X; Lu K; Chen N; Li P; Wang X Oncol Rep; 2013 Nov; 30(5):2427-34. PubMed ID: 24026139 [TBL] [Abstract][Full Text] [Related]
19. Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas. Sundaresan A; Claypool K; Mehta K; Lopez-Berestein G; Cabanillas F; Ford RJ Cell Growth Differ; 1997 Oct; 8(10):1071-82. PubMed ID: 9342185 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma. Zhu FQ; Zeng L; Tang N; Tang YP; Zhou BP; Li FF; Wu WG; Zeng XB; Peng SS Oncol Res; 2016 Oct; 24(6):415-427. PubMed ID: 28281962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]